Galvanize Therapeutics
Galvanize Therapeutics: Global leader in energy-based medical technology for diverse healthcare solutions.
Founded
2022Galvanize Therapeutics: Global leader in energy-based medical technology for diverse healthcare solutions.
Founded with the mission to revolutionize healthcare through energy-based medical technology, Galvanize Therapeutics aims to become a global leader in delivering innovative therapeutic solutions. The company specializes in designing and developing Pulsed Electric Field (PEF) Systems, such as the Aliya™ PEF System, to achieve meaningful and lasting outcomes for patients. Galvanize Therapeutics focuses on treating a range of diseases by impacting biological processes, with an initial emphasis on oncology.
Galvanize Therapeutics has garnered attention from notable investors and industry leaders, contributing to its rapid growth and innovation. The company's key achievements include the successful development and deployment of its Aliya™ PEF System, which has shown promising results in clinical settings. By transforming energy into effective therapy, Galvanize Therapeutics is making a significant impact on the medical device industry and improving patient outcomes worldwide.
Companies similar to Galvanize Therapeutics include Field Medical, Thermedical, Eliaz Therapeutics and Enavate Sciences.
Galvanize Therapeutics was founded in 2022.
Galvanize Therapeutics' headquarters is located in San Carlos, CA, US.
Galvanize Therapeutics' most recent funding round was for $100M (USD) in September 2022.
As of Sep 15, 2022, Galvanize Therapeutics has disclosed funding of $148.5M (USD). Undisclosed round amounts are excluded.
Galvanize Therapeutics has 122 employees as of Feb 5, 2024.
Enavate Sciences
